Share
𝕏 Facebook LinkedIn

Effects of low-level light therapy on streptozotocin-induced diabetic kidney

PAPER manual J Photochem Photobiol B 2010 Animal study Effect: benefit Evidence: Low

Abstract

Hyperglycemia causes oxidative damage in tissues prone to complications in diabetes. Low-level light therapy (LLLT) in the red to near infrared range (630-1000nm) has been shown to accelerate diabetic wound healing. To test the hypothesis that LLLT would attenuate oxidative renal damage in Type I diabetic rats, male Wistar rats were made diabetic with streptozotocin (50mg/kg, ip), and then exposed to 670nm light at a dose of 9J/cm(2) once per day for 14weeks. The activity and expression of catalase and the activity of Na K-ATPase increased in kidneys of light-treated diabetic rats, whereas the activity and expression of glutathione peroxidase and the expression of Na K-ATPase were unchanged. LLLT lowered the values of serum BUN, serum creatinine, and BUN/creatinine ratio. In addition, LLLT augmented the activity and expression of cytochrome c oxidase, a primary photoacceptor molecule in the mitochondrial respiratory chain, and reduced the formation of the DNA adduct 8-hydroxy-2'-deoxyguanosine in kidney. LLLT improved renal function and antioxidant defense capabilities in the kidney of Type I diabetic rats. Thus, 670nm LLLT may be broadly applicable to the amelioration of renal complications induced by diabetes that disrupt antioxidant defense mechanisms.

AI evidence extraction

At a glance
Study type
Animal study
Effect direction
benefit
Population
Male Wistar rats with streptozotocin-induced Type I diabetes
Sample size
—
Exposure
optical (red/near-infrared) low-level light therapy (LLLT) · 9 J/cm^2 once per day for 14 weeks
Evidence strength
Low
Confidence: 74% · Peer-reviewed: yes

Main findings

Diabetic rats exposed to 670 nm light (9 J/cm^2 daily for 14 weeks) showed increased kidney catalase activity/expression and increased Na,K-ATPase activity, with no change reported for glutathione peroxidase activity/expression and Na,K-ATPase expression. Light therapy lowered serum BUN, serum creatinine, and the BUN/creatinine ratio, increased cytochrome c oxidase activity/expression, and reduced kidney 8-OHdG formation; authors conclude renal function and antioxidant defenses improved.

Outcomes measured

  • Kidney catalase activity and expression
  • Kidney Na,K-ATPase activity and expression
  • Kidney glutathione peroxidase activity and expression
  • Serum BUN
  • Serum creatinine
  • BUN/creatinine ratio
  • Cytochrome c oxidase activity and expression
  • Kidney 8-hydroxy-2'-deoxyguanosine (8-OHdG) DNA adduct formation
  • Renal function
  • Antioxidant defense in kidney

Limitations

  • Sample size not reported in provided abstract/metadata
  • Animal model (streptozotocin-induced diabetic rats) may not generalize to humans
  • Exposure parameters beyond wavelength, dose, and schedule (e.g., irradiance, device details) not provided in abstract
View raw extracted JSON
{
    "study_type": "animal",
    "exposure": {
        "band": "optical (red/near-infrared)",
        "source": "low-level light therapy (LLLT)",
        "frequency_mhz": null,
        "sar_wkg": null,
        "duration": "9 J/cm^2 once per day for 14 weeks"
    },
    "population": "Male Wistar rats with streptozotocin-induced Type I diabetes",
    "sample_size": null,
    "outcomes": [
        "Kidney catalase activity and expression",
        "Kidney Na,K-ATPase activity and expression",
        "Kidney glutathione peroxidase activity and expression",
        "Serum BUN",
        "Serum creatinine",
        "BUN/creatinine ratio",
        "Cytochrome c oxidase activity and expression",
        "Kidney 8-hydroxy-2'-deoxyguanosine (8-OHdG) DNA adduct formation",
        "Renal function",
        "Antioxidant defense in kidney"
    ],
    "main_findings": "Diabetic rats exposed to 670 nm light (9 J/cm^2 daily for 14 weeks) showed increased kidney catalase activity/expression and increased Na,K-ATPase activity, with no change reported for glutathione peroxidase activity/expression and Na,K-ATPase expression. Light therapy lowered serum BUN, serum creatinine, and the BUN/creatinine ratio, increased cytochrome c oxidase activity/expression, and reduced kidney 8-OHdG formation; authors conclude renal function and antioxidant defenses improved.",
    "effect_direction": "benefit",
    "limitations": [
        "Sample size not reported in provided abstract/metadata",
        "Animal model (streptozotocin-induced diabetic rats) may not generalize to humans",
        "Exposure parameters beyond wavelength, dose, and schedule (e.g., irradiance, device details) not provided in abstract"
    ],
    "evidence_strength": "low",
    "confidence": 0.7399999999999999911182158029987476766109466552734375,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "low-level light therapy",
        "LLLT",
        "670 nm",
        "near-infrared",
        "red light",
        "diabetes",
        "streptozotocin",
        "Type I diabetic rats",
        "kidney",
        "renal function",
        "oxidative damage",
        "catalase",
        "glutathione peroxidase",
        "Na,K-ATPase",
        "cytochrome c oxidase",
        "8-hydroxy-2'-deoxyguanosine",
        "8-OHdG"
    ],
    "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.